Preferences for medication attributes among patients with type 2 diabetes mellitus in the UK

A quantitative assessment of patient barriers to insulin

(2011) R. Casciano et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

PMC73 EVALUATION OF GLP-1 PRODUCT ATTRIBUTES IN TREATING PEOPLE WITH TYPE-2 DIABETES IN US: COMPARING TIME-TRADEOFF AND WILLINGNESS-TO-PAY METHODOLOGIES

(2011) E Zanutto et al.   VALUE IN HEALTH

Willingness to pay for health improvements associated with anti-diabetes treatments for people with type 2 diabetes

(2010) J. Jendle et al.   CURRENT MEDICAL RESEARCH AND OPINION

Sodium-Glucose Co-Transport Inhibitors

(2010) Joshua J. Neumiller et al.   DRUGS

Preferences of diabetes patients and physicians: A feasibility study to identify the key indicators for appraisal of health care values

(2010) Franz Porzsolt et al.   Health and Quality of Life Outcomes

A comparison of preferences for two GLP-1 products – liraglutide and exenatide – for the treatment of type 2 diabetes

(2010) Michael Polster et al.   JOURNAL OF MEDICAL ECONOMICS

Treatment preferences and medication adherence of people with Type 2 diabetes using oral glucose-lowering agents

(2009) A. B. Hauber et al.   DIABETIC MEDICINE

A valuation of patients' willingness-to-pay for insulin delivery in diabetes

(2009) Camila Guimarães et al.   INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE

Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes

(2008) D. M. Nathan et al.   DIABETES CARE